The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
Open accessAbstract
Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases. We describe the high-resolution crystal structures of the catalytic domains of PDE4B, PDE4D, and PDE5A with ten different inhibitors, including the drug candidates cilomilast and roflumilast, for respiratory diseases. These cocrystal structures reveal a common scheme of inhibitor binding to the PDEs: (i) a hydrophobic clamp formed by highly conserved hydrophobic residues that sandwich the inhibitor in the active site; (ii) hydrogen bonding to an invariant glutamine that controls the orientation of inhibitor binding. A scaffold can be readily identified for any given inhibitor based on the formation of these two types of conserved interactions. These structural insights will enable the design of isoform-selective inhibitors with improved binding affinity and should facilitate the discovery of more potent and selective PDE inhibitors for the treatment of a variety of diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Aromatic-Aromatic Interaction: A Mechanism of Protein Structure Stabilization
Burley, S. K., & Petsko, G. A. (1985) · Science · doi:10.1126/science.3892686 · Cited by 2,524
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
The integration of macromolecular diffraction data
Leslie, A. G. W. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905039107 · Cited by 1,341
Efficient anisotropic refinement of macromolecular structures using FFT
Murshudov, G. N., Vagin, A. A., Lebedev, A., Wilson, K. S., & Dodson, E. J. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744499801405x · Cited by 936
Cyclic nucleotide research — still expanding after half a century
Beavo, J. A., & Brunton, L. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm911 · Cited by 903
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
BALLARD, S. A., GINGELL, C. J., TANG, K., TURNER, L. A., PRICE, M. E., & NAYLOR, A. M. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63299-3 · Cited by 591
Cyclic nucleotide phosphodiesterases: Relating structure and function
Francis, S. H., Turko, I. V., & Corbin, J. D. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)65001-8 · Cited by 564
Cyclic GMP Phosphodiesterase-5: Target of Sildenafil
Corbin, J. D., & Francis, S. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13729 · Cited by 531
Cyclic nucleotide phosphodiesterases
Essayan, D. M. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.119555 · Cited by 503
The Molecular Biology of Cyclic Nucleotide Phosphodiesterases
(1999) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60718-7 · Cited by 435
Integration of macromolecular diffraction data
Leslie, A. G. W. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744499900846x · Cited by 409
Anti-Inflammatory and Immunomodulatory Potential of the Novel PDE4 Inhibitor Roflumilast in Vitro
Hatzelmann, A., & Schudt, C. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29537-9 · Cited by 398
Jin, S.-L. C., & Conti, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122041599 · Cited by 367
Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and Specificity
Xu, R. X., Hassell, A. M., Vanderwall, D., Lambert, M. H., Holmes, W. D., Luther, M. A., Rocque, W. J., Milburn, M. V., Zhao, Y., Ke, H., et al. (2000) · Science · doi:10.1126/science.288.5472.1822 · Cited by 335
Self-citationPhosphodiesterase 5 inhibitors: current status and potential applications
Rotella, D. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd893 · Cited by 306
A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases
Zhang, K. Y. J., Card, G. L., Suzuki, Y., Artis, D. R., Fong, D., Gillette, S., Hsieh, D., Neiman, J., West, B. L., Zhang, C., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.005 · Cited by 300
Self-citationStructure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules
Sung, B.-J., Yeon Hwang, K., Ho Jeon, Y., Lee, J. I., Heo, Y.-S., Hwan Kim, J., Moon, J., Min Yoon, J., Hyun, Y.-L., Kim, E., et al. (2003) · Nature · doi:10.1038/nature01914 · Cited by 281
Gresser, U., & Gleiter, C. H. (2002) · PubMed · Cited by 268
Robichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15506 · Cited by 267
Pharmacology of phosphodiesterase inhibitors
(2005) · Therapeutic Strategies in COPD · doi:10.1201/b14809-12 · Cited by 261
PHARMACOLOGY OF PHOSPHODIESTERASE‐5 INHIBITORS
Corbin, J., & Francis, S. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11296.x · Cited by 260
Robichaud, A., Stamatiou, P. B., Jin, S.-L. C., Lachance, N., MacDonald, D., Laliberté, F., Liu, S., Huang, Z., Conti, M., & Chan, C.-C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215506 · Cited by 259
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling
Mehats, C., Andersen, C. B., Filopanti, M., Jin, S.-L. C., & Conti, M. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00523-9 · Cited by 257
Souness, J. E., Aldous, D., & Sargent, C. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00185-5 · Cited by 244
In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor
Bundschuh, D. S., Eltze, M., Barsig, J., Wollin, L., Hatzelmann, A., & Beume, R. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29538-0 · Cited by 236
Automated protein crystal structure determination using elves
Holton, J., & Alber, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306241101 · Cited by 207
Phosphodiesterases and Cyclic Nucleotide Signaling in Endocrine Cells
Conti, M. (2000) · Molecular Endocrinology · doi:10.1210/me.14.9.1317 · Cited by 191
Bolger, G. B., Peden, A. H., Steele, M. R., MacKenzie, C., McEwan, D. G., Wallace, D. A., Huston, E., Baillie, G. S., & Houslay, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303269200 · Cited by 168
Huai, Q., Liu, Y., Francis, S. H., Corbin, J. D., & Ke, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311556200 · Cited by 130
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
Alvarez, R., Sette, C., Yang, D., Eglen, R. M., Wilhelm, R. S., Shelton, E. R., & Conti, M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10513-0 · Cited by 129
Huai, Q., Wang, H., Sun, Y., Kim, H.-Y., Liu, Y., & Ke, H. (2003) · Structure · doi:10.1016/s0969-2126(03)00123-0 · Cited by 123
Scapin, G., Patel, S. B., Chung, C., Varnerin, J. P., Edmondson, S. D., Mastracchio, A., Parmee, E. R., Singh, S. B., Becker, J. W., der Ploeg, L. H. T. V., et al. (2004) · Biochemistry · doi:10.1021/bi049868i · Cited by 122
The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysis,
Huai, Q., Colicelli, J., & Ke, H. (2003) · Biochemistry · doi:10.1021/bi034653e · Cited by 122
IC351 (tadalafil, Cialis): update on clinical experience
Porst, H. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900807 · Cited by 116
Crystal structure of phosphodiesterase 4D and inhibitor complex1
Lee, M. E., Markowitz, J., Lee, J., & Lee, H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03396-3 · Cited by 114
McPhee, I., Yarwood, S. J., Scotland, G., Huston, E., Beard, M., Ross, A. H., Houslay, E. S., & Houslay, M. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11796 · Cited by 108
Huai, Q., Wang, H., Zhang, W., Colman, R. W., Robinson, H. H., & Ke, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401120101 · Cited by 95
Adaptation in cyclic AMP signalling processes: A central role for cyclic AMP phosphodiesterases
Houslay, M. D. (1998) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1997.0221 · Cited by 86
Imidazo[5,1-f][1,2,4]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors
Haning, H., Niewöhner, U., Schenke, T., Es‐Sayed, M., Schmidt, G., Lampe, T. F. J., & Bischoff, E. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00030-6 · Cited by 76
Terry, R., Cheung, Y.-F., Præstegaard, M., Baillie, G. S., Huston, E., Gall, I., Adams, D. R., & Houslay, M. D. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00092-5 · Cited by 39
Cited by
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fleming, F. F., Yao, L., Ravikumar, P. C., Funk, L., & Shook, B. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100762r · Cited by 1,754
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
Metadata
- Authors
- Card, G. L., England, B. P., Suzuki, Y., Fong, D., Powell, B., Lee, B., Luu, C., Tabrizizad, M., Gillette, S., Ibrahim, P. N., Artis, D. R., Bollag, G., Milburn, M. V., Kim, S.-H., Schlessinger, J., & Zhang, K. Y. J.
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 12
- Issue
- 12
- Pages
- 2233-2247
- ISSN
- 0969-2126 (ISSN-L)
- OpenAlex
- W2119774957
- Cited by
- 432
- References
- 43
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.